Hikma Taps Celltrion Again To Bring In MENA Stelara Biosimilar
Adalimumab Biosimilar Only Recently Added To Long-Term Partnership
Hikma has signed another partnership agreement to gain Middle East and North Africa commercialization rights to an ustekinumab biosimilar – although not with its US partner, Bio-Thera Solutions.
